Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005391710 | SCV006046187 | uncertain significance | Inborn genetic diseases | 2025-02-08 | criteria provided, single submitter | clinical testing | The c.11225A>G (p.E3742G) alteration is located in exon 39 (coding exon 39) of the PKD1 gene. This alteration results from a A to G substitution at nucleotide position 11225, causing the glutamic acid (E) at amino acid position 3742 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |